Akero Therapeutics, Inc. (AKRO)

Dec 9, 2025 - AKRO was delisted (reason: acquired by NVO)

54.65

0.00 (0.00%)

Inactive · Last trade price on Dec 8, 2025

Akero Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 5, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	4,499	1,942	1,301	2,563	738	896
Market Cap Growth	110.40%	49.28%	-49.24%	247.29%	-17.63%	41.33%
Enterprise Value	3,511	1,191	714	2,199	524	606
Last Close Price	54.65	27.82	23.35	54.80	21.15	25.80

Price Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 5, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
PB Ratio	4.57	2.59	2.43	7.85	4.36	3.46
P/TBV Ratio	4.70	2.59	2.43	7.85	4.36	3.46

Financial Efficiency

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 5, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Debt / Equity Ratio	0.00	0.05	0.05	0.03	0.01	0.01
Quick Ratio	15.48	18.69	28.75	18.42	7.49	20.47
Current Ratio	15.84	19.38	29.27	18.61	7.70	20.70
Return on Equity (ROE)	-34.53%	-39.22%	-35.22%	-45.20%	-47.11%	-40.89%
Return on Assets (ROA)	-22.63%	-25.37%	-23.06%	-26.07%	-26.90%	-24.35%
Return on Invested Capital (ROIC)	-23.81%	-26.47%	-24.03%	-28.33%	-29.25%	-25.73%
Return on Capital Employed (ROCE)	-34.50%	-36.30%	-30.80%	-34.10%	-59.20%	-30.80%

Yields

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 5, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Earnings Yield	-6.51%	-12.98%	-11.67%	-4.37%	-13.66%	-8.84%
FCF Yield	-5.56%	-11.90%	-11.18%	-3.61%	-10.80%	-7.92%
Buyback Yield / Dilution	-23.38%	-27.71%	-34.84%	-11.94%	-10.69%	-108.77%

SEC Filings: 10-K · 10-Q